Full Issue

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Jan/Feb 2018- Volume 22, Number 1

Purchase the entire back issue in electronic PDF or print format.

(Select Format)

Purchase individual articles by selecting the article in the table below...

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Individual Articles - Jan/Feb 2018- Volume 22, Number 1
PreScription: 2017--Some Good Things Happened and Some Others Allen Loyd V Jr	Jan/Feb 2018 Pg. 4
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Pain: Systematic Review of Pharmacy Compounding of Pain Medication Shawaqfeh Mohammad S, Harrington Catherine	Jan/Feb 2018 Pg. 19-24
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Blankenship Cynthia	Jan/Feb 2018 Pg. 26-28
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients McElhiney Linda F	Jan/Feb 2018 Pg. 30-39
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Kosinski Tracy M, Brown Michael C, Zavala Pedro J	Jan/Feb 2018 Pg. 41-46
Calculations Stockton Shelly J	Jan/Feb 2018 Pg. 48
Glutamate and Aspartate Cardioplegia Additive Solution Allen Loyd V Jr	Jan/Feb 2018 Pg. 50
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Metronidazole 50 mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 52
Miconazole 10% in Recura Topical Cream Allen Loyd V Jr	Jan/Feb 2018 Pg. 53
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Sodium Citrate 9% Nasal Spray for Olfactory Disorders Allen Loyd V Jr	Jan/Feb 2018 Pg. 57
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Voriconazole 40-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 59
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Song Guiyun, Banov Daniel, Bassani August S	Jan/Feb 2018 Pg. 60-65
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H	Jan/Feb 2018 Pg. 66-75
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94

	PDF — $95
	Print Copy — $95